These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
403 related items for PubMed ID: 37283097
1. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs. Xu C, Chen A, Mao C, Cui B. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr 25; 52(2):139-147. PubMed ID: 37283097 [Abstract] [Full Text] [Related]
3. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Huang Y, Gong P, Su L, Zhang M. Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210 [Abstract] [Full Text] [Related]
4. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer. Pan Y, Zhang Q, Zhang H, Kong F. Funct Integr Genomics; 2023 Jan 14; 23(1):38. PubMed ID: 36640225 [Abstract] [Full Text] [Related]
5. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs. Zhang X, Ye Z, Xiao G, He T. Comput Biol Med; 2023 Jun 14; 159():106905. PubMed ID: 37060773 [Abstract] [Full Text] [Related]
7. Construction of a prediction model for prognosis of bladder cancer based on the expression of ion channel-related genes. Zhang D, Yin G, Zheng S, Chen Q, Li Y. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug 25; 52(4):499-509. PubMed ID: 37643983 [Abstract] [Full Text] [Related]
9. Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer. Huang G, Huang Y, Zhang C, Jiang Y, Ye Z, He C, Yu F, Chen Z, Xi X. Sci Rep; 2022 Dec 10; 12(1):21386. PubMed ID: 36496537 [Abstract] [Full Text] [Related]
10. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X, Chen C, Li X, Yang J, Zhang W, Wang X, Zhang H, Peng M, Li L, Luo P. Front Oncol; 2023 Dec 10; 13():972558. PubMed ID: 37064115 [Abstract] [Full Text] [Related]
13. Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma. Zhu S, Li H, Fan Y, Tang C. BMC Urol; 2023 Jul 21; 23(1):124. PubMed ID: 37479989 [Abstract] [Full Text] [Related]
15. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L, Xiao K, Dong Z, Meng T, Cheng X, Xu Y. J Cancer Res Clin Oncol; 2023 Sep 21; 149(12):10543-10559. PubMed ID: 37291405 [Abstract] [Full Text] [Related]
16. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. Zhu Y, He J, Li Z, Yang W. BMC Bioinformatics; 2023 Feb 03; 24(1):37. PubMed ID: 36737692 [Abstract] [Full Text] [Related]
20. Cuproptosis-related long noncoding RNAs predicts overall survival and reveal immune microenvironment of bladder cancer. Wang H, Lv Z, Xia H, Tang R, Liu M, Wang J, Wang J. Heliyon; 2023 Dec 03; 9(12):e21153. PubMed ID: 38094043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]